Skip to Content

DocuSign Earnings: Innovates and Expands Despite Macroenvironment

Solid results exceed expectations; DocuSign stock attractive for patient investors.

Illustration of green laptop with a line graph on the screen outlined in blue and part of a blue laptop with a line graph on the screen outlined in orange depicting the software industries
Securities In This Article
DocuSign Inc
(DOCU)

Key Morningstar Metrics for DocuSign

What We Thought of DocuSign’s Earnings

Narrow-moat DocuSign DOCU reported solid second-quarter results, with both top-line and non-GAAP operating margin exceeding our expectations. Operating margin remains strong as a result of recent headcount reductions. Margins are expected to decline throughout the remainder of the year, though, as DocuSign continues to innovate and invest in its products such as ID Verification and the expanded availability of DocuSign Monitor.

Despite the macroeconomic headwinds, good results and a raised full-year outlook indicate that DocuSign is confident enough in its core business to invest in its products even in a difficult operating environment. DocuSign has executed well by focusing on margins, streamlining its sales approach, and accelerating product innovation.

DocuSign Stock Undervalued

We keep our fair value estimate of $74. We see shares as attractive for patient investors but continue to prefer some of our wide-moat names as macroeconomic uncertainty persists.

Total revenue grew 11% year over year to $688 million, exceeding the high end of guidance at $679 million. Subscription revenue grew 11% year over year to $669 million, while services grew 8%. Within the international segment, expansion remains the primary goal, and DocuSign has demonstrated the ability to execute, as it grew 17% year over year, representing 26% of total revenue. Billings were $711 million, up 10% year over year, based on a higher rate of time renewals.

Net dollar retention declined sequentially, consistent with recent trends, to 102%, and management expects that figure to trend further down in the third quarter. As a reminder, DocuSign’s normal range is 112% to 119%, but the downtick was not unexpected as buying patterns are more modest, expansion remains constrained, and slight churn occurs amid the difficult macroenvironment.

Non-GAAP operating margin was 24.7%, up significantly from 18.0% a year ago, and was driven by recent headcount reductions when compared with the previous year.

DocuSign Stock Price

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.

More in Stocks

About the Author

Dan Romanoff

Senior Equity Analyst
More from Author

Dan Romanoff, CPA, is a senior equity research analyst on the technology, media, and telecommunications team for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. He covers software.

Before Joining Morningstar in 2019, Romanoff spent 12 years in buy-side equity research covering the technology and telecommunications sectors, most recently at Holland Capital Management. Prior to that, he spent five years in sell-side equity research as an associate analyst at UBS and a senior analyst at Credit Suisse covering various areas within technology, including hardware, software, and semiconductors. Romanoff also has worked as an auditor and in valuation services for major public accounting firms.

Romanoff holds a bachelor’s degree in accountancy and a Master of Business Administration in finance, both from the University of Illinois at Urbana-Champaign. He also holds the Certified Public Accountant and Accredited in Business Valuation designations.

Sponsor Center